Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
This NOFO supports research and preclinical development of highly effective next-generation malaria vaccines, using new tools such as structure-based immunogen design, improved vaccine formulations, and combination approaches. The intent is long-lasting protection with potential to serve as a platform model for other mosquito-borne diseases, strengthening U.S. public health security. Clinical …
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
National Institutes of Health
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Deployed Warfighter Protection FY27
ACC-APG-Detrick
-
DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
Dept. of the Army -- USAMRAA
-
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers